ARDENA
LIVE

Serial Number

79213596

Owner

Pharmavize nv

Attorney

Clifford D. Hyra

Filing Date

Mar 8, 2017

Add to watchlist:

No watchlists yet
View on USPTO

ARDENA Trademark

Serial Number: 79213596 • Registration: 5357360

ARDENA is a trademark filed by Pharmavize nv on March 8, 2017. The trademark is classified under Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Pharmavize nv

Kleimoer 4
Mariakerke B-9030 , BE

Entity Type: 32

Trademark Details

Filing Date

March 8, 2017

Registration Date

December 19, 2017

Published for Opposition

October 3, 2017

Goods & Services

Pharmaceutical research and pharmaceutical development; inspection of pharmaceutical products; research on pharmaceutical products; testing of pharmaceutical products; scientific investigations of pharmaceutical products for medical purposes; pharmaceutical development of drugs; development of pharmaceutical products; medical and pharmaceutical research services; consultancy pertaining to pharmacology; qualitative evaluation of pharmaceuticals; research relating to pharmaceuticals; development of pharmaceutical preparations and medicines; laboratory research regarding pharmaceutical products; research in the field of pharmacogenetics; scientific research in the field of pharmaceutics; testing of the effectiveness of pharmaceutical products; research and development services in the field of biology, gynecology, biotechnology, for others in the pharmaceutical industry; conducting clinical trials for others in the field of pharmaceutical products; research and development in the pharmaceutical field and biotechnology; consultancy relating to research and development in the pharmaceutical field; providing scientific research information in the field of clinical trials of pharmaceuticals; conducting early evaluations in the field of new pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research; [ providing scientific advice in relation to carbon offsetting; ] scientific testing; research and development services; conducting scientific feasibility studies; scientific analysis, namely, chemical analysis; [ scientific and technological services, namely, design in the field of computer networking hardware, computer datacenter architecture, ] scientific and technological services, namely, scientific research, analysis, testing, in the field of pharmaceuticals; providing scientific information in the field of biology, gynecology, biotechnology; providing of scientific research information in the field of, physics, genetics, pharmaceutical, biotechnology, gynecology; scientific medical research; scientific research for medical purposes; research in the field of physics, bacteriology, gynecology, biotechnology; contract research related to molecular sciences; research relating to molecular sciences; scientific research related to chemistry and biology; providing scientific research information in the field of genetics, physics, pharmaceuticals, biotechnology, organic chemistry

Legal consultation and advice; reviewing standards and practices to assure compliance with pharmaceutical laws and regulations

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Mar 5, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 8, 2026 NREP
PARTIAL INVALIDATION PROCESSED BY THE IB
Jul 26, 2025 INNP
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 30, 2025 INPS
INVALIDATION PROCESSED
Jun 30, 2025 INPC
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Mar 29, 2025 INPR
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Jul 29, 2024 NA71
REGISTERED-SEC.71 ACCEPTED
Jul 29, 2024 71AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 28, 2024 APRE
TEAS SECTION 71 RECEIVED
Nov 7, 2023 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Dec 19, 2022 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
May 12, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 27, 2018 FICS
FINAL DISPOSITION PROCESSED
Mar 27, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 19, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Dec 19, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 3, 2017 NPUB
PUBLISHED FOR OPPOSITION
Oct 3, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2017 NONP
REFUSAL PROCESSED BY IB
Sep 8, 2017 RFNP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 24, 2017 CNSA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 23, 2017 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 23, 2017 REAP
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 23, 2017 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 21, 2017 RFCS
REFUSAL PROCESSED BY MPU
Aug 21, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 18, 2017 RFCR
NON-FINAL ACTION WRITTEN
Aug 17, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 11, 2017 MAFR
ASSIGNED TO EXAMINER
Aug 7, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 7, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 3, 2017 REPR